Compare DMRA & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | PEB |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | 7 | 52 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2020 | N/A |
| Metric | DMRA | PEB |
|---|---|---|
| Price | $21.40 | $17.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 11 |
| Target Price | ★ $43.00 | $13.30 |
| AVG Volume (30 Days) | 356.8K | ★ 1.7M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.50 | $8.88 |
| 52 Week High | $28.76 | $16.88 |
| Indicator | DMRA | PEB |
|---|---|---|
| Relative Strength Index (RSI) | 31.88 | 79.68 |
| Support Level | $16.50 | $13.77 |
| Resistance Level | $26.66 | N/A |
| Average True Range (ATR) | 1.61 | 0.45 |
| MACD | -0.37 | 0.18 |
| Stochastic Oscillator | 13.54 | 96.29 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.